For people with multiple food allergies, a drug already approved for asthma and chronic hives may prevent severe reactions to peanuts, eggs, milk and other foods, new research shows. is suggested.
An initial analysis of clinical trial data supported by the National Institute of Allergy and Infectious Diseases found that 165 children and adolescents who received injections of the drug Xolair experienced higher levels of hypersensitivity without causing allergic reactions compared to other children. I was able to ingest a large amount of food. Dr. Alkis Togias, chief of NIAID's Division of Allergy, Asthma and Airway Biology, said the patient was treated with a placebo.
“The main advantages of this drug are that it covers multiple foods and that it has been around for about 20 years and its safety profile is well known,” Togias said.
The monoclonal antibody omalizumab, sold as Xolair and developed by Genentech and Novartis, is already used as a treatment for asthma. This drug has been shown to reduce allergic asthma attacks and hives in clinical trials.
Read the full story NBCNews.com.
